Blog

Bristol Myers (BMY) is looking to boost its bottom-line growth as generic competition for legacy drugs (Revlimid, Pomalyst, Sprycel, and Abraxane) pulls down the top line.

In 2023, BMY initiated a

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 19th:

Gold Fields Limited GFI: This company which is one of the world's largest

Shares of Fiverr International (FVRR) have gained 9.4% over the past four weeks to close the last trading session at $25.21, but there could still be a solid upside left in the stock if short-term

Shattuck Labs, Inc. (STTK) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, STTK's 50-day simple moving average crossed

Shares of XOMA Royalty (XOMA) have gained 14.8% over the past four weeks to close the last trading session at $37.59, but there could still be a solid upside left in the stock if short-term price

From a technical perspective, Jefferies Financial Group Inc. (JEF) is looking like an interesting pick, as it just reached a key level of support. JEF's 50-day simple moving average crossed above

Sterling Infrastructure, Inc. STRL is quietly carving out a commanding role in the buildout of America’s digital backbone. The company’s second-quarter 2025 results highlighted this shift, with

Motorola Solutions, Inc. MSI has introduced its WAVE PTX communication platform in the Dominican Republic, expanding access to secure and instant broadband push-to-talk (PTT) services. Notably

Stride, Inc. LRN closed fiscal 2025 with another record year, underscoring its momentum in the school choice movement. Fourth-quarter revenues climbed 22% year over year to $653.7 million, while

Incyte INCY announced that the FDA has approved the label expansion of Opzelura (ruxolitinib) cream 1.5%.

Opzelura, a topical Janus kinase (JAK) inhibitor, is now approved for the short-term and

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

PTC Inc. (PTC) recently augmented its product portfolio with the launch of the Arena AI Assistant—an artificial intelligence (AI)-powered guide embedded directly into its Arena product lifecycle

According to a CNBC report, the U.S. Supreme Court is set to review the legality of President Trump’s major import tariffs in hearings scheduled for Nov. 5. As a result, uncertainty persists, and

Medifast, Inc. MED is strategically positioning itself at the intersection of health, nutrition and lifestyle coaching. The company is expanding its portfolio of nutritionally-balanced meals and

Exxon Mobil Corporation XOM, a U.S. oil and gas giant, generates a significant portion of its revenues from exploration and production activities. The company is advancing major oil projects in two